Market header image

Bulletins

You are here

2019-0215 - Delist - MPX Bioceutical Corporation (MPX)

Le 6 février/February 2019

Following the completion of the Arrangement as set out in the Company's management information circular (the "Circular") dated December 11, 2018 and approved by the Company's security holders at the Company's special meeting held on January 15, 2019 (the "Special Meeting"), the common shares of MPX Bioceutical Corporation will be delisted at the market close today February 6, 2019.

As part of the Arrangement, MPX Bioceutical Corporation, amalgamated with 1183271 B.C. Unlimited Liability Company, a wholly owned subsidiary of iAnthus Capital Holdings, Inc. (CSE: IAN) ("iAnthus") created for the purposes of the Arrangement.

Date: Market Close/Clôture du marchés le 6 février/February 2019
Symbol(s)/Symbole(s): MPX

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse:  Listings@thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

04_20_CSE_Talks_Montreal_Website

CSE Talks Montreal: Four Months Into Legalization ... What Now?

Wednesday, February 20, 2019 -
4:00pm to 7:00pm
02_21_CSE_Talks_Ottawa_Website_v3

CSE Talks Ottawa: Four Months Into Legalization ... What Now?

Thursday, February 21, 2019 -
12:00pm to 3:00pm
02_26_PreDac_Toronto_2019_Website

PreDAC Toronto 2019

Tuesday, February 26, 2019 -
3:00pm to 5:30pm

Advertisement

Publicité